Answers are grounded in this paper and cite their sources.
A series of new substituted phenyl-2-(perchloro-1H-benzo[d][1,2,3]triazol-1-yl)ethan-1-one derivatives 3(a-j) was synthesized, and evaluated for antimycobacterial and antimicrobial activity. Among all the tested compounds, compound 3h exhibited the highest antimycobacterial and antibacterial activity, comparable to the standard drug. Finally, the binding mode analysis of the highly active compounds was performed in the active binding site, the co-crystallized structure of Mycobacterium tuberculosis (PDB ID 2×22) and glucosamine-6-phosphate synthase (PDB ID 2VF5).
No takes yet. Share an insight, caveat, or question.
Maiti et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: